Nestlé is in trouble as it pushes prices up
Nestlé has pushed up prices for customers and now it's suffering the consequences, leaving a spotlight on its performance and shares
Food giant Nestlé has been left “counting the cost” of pushing up prices of its most popular brands beyond the reach of “increasingly squeezed customers”, says Sian Bradley in The Times. It has been forced to cut its sales guidance again.
Underlying sales increased by an unexpectedly weak 2% in the first nine months of this year, which means that it now expects sales to rise by only 2% over the full year, “the lowest rate since the turn of the century”. Experts have blamed the malaise on Nestlé’s decision “not to ease up quickly enough on price increases” as inflation has cooled, as many of its competitors did.
Nestlé’s poor numbers explain why former CEO Mark Schneider was ousted in August, says Aimee Donnellan for Breakingviews. It’s not just the poor sales figures. The company’s profitability “is also under pressure”, with margins weakening. While this could be fixed by a “hefty spend on sales and marketing”, possibly funded by selling some of its 20% stake in the beauty giant L’Oréal, the company also faces the medium- and long-term challenge that its portfolio “is full of foods that may go out of fashion” amid growing concern over rising rates of obesity.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
How are Nestlé shares performing?
The “tumbling targets” follow trouble with IT last year and an “uncomfortable regulatory investigation” in France over allegations related to the purification of bottled mineral water, says Miles Costello in The Telegraph. As a result, Nestlé’s shares are down 14% in a year and close to their cheapest valuation in 10 years, at 18.4 times forward earnings.
But the group still has some “distinct competitive advantages”, including the “distribution clout created by its scale”, buying power with suppliers, and “diverse household-name brands that underpin pricing power”. Even concerns about health need to be seen in the context of the firm’s “increasing emphasis on health and nutrition”. The “ingredients exist for success”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
Affordable Art Fair: The art fair for beginnersChris Carter talks to the Affordable Art Fair’s Hugo Barclay about how to start collecting art, the dos and don’ts, and more
-
Top reasons homeowners use equity release to access £4 trillion housing wealthThe equity release market grew 11% in 2025, according to the latest data, as the over 55s rushed to make use of the trillions of pounds tied up in their homes. Here’s what they did with the money.
-
Affordable Art Fair: The art fair for beginnersChris Carter talks to the Affordable Art Fair’s Hugo Barclay about how to start collecting art, the dos and don’ts, and more
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth